Plain-English translation of NCT07680868 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is evaluating a genetic test called Caris Chromoseq that helps doctors understand the genetic changes in blood cancer cells. Researchers want to see how well this test works compared to the standard genetic tests doctors currently use, and whether it's faster and easier to use.
Patients with blood cancers like AML, MDS, or MPN need genetic testing to help doctors understand their disease and plan treatment. This study exists to see if the new test provides the same helpful information as current standard tests while being faster and easier to perform.
You likely qualify if…
You likely don't qualify if…
If you join, your doctor will order the Caris Chromoseq test as part of your regular cancer care, and researchers will collect information about how this test compares to the standard genetic tests you're also receiving. You won't need to do anything extra beyond what your doctor already planned — the study simply involves sharing your medical data and test results with the research team.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States
~300 participants
Started
July 2026
Primary completion
July 2029
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mary Baker
Caris Science, Inc.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.